Human Reproductive Technologies Market Increasing adoption of maternal mortality to Boom Growth of the Human Reproductive Technologies Market, Key players | Abbott, Evofem Biosciences, Actavis Generics

Emergency contraception can be used after intercourse to stop before the pregnancy starts. There are two main types of emergency contraceptives: emergency contraceptive pills (ECPs) and copper tea intrauterine devices (IUDs). Some reproductive techniques are being developed, counting artificial insemination, germ selection techniques, in vitro parthenogenesis, and reprogenetics.

Receive A Full PDF Sample Copy Of Report @
https://www.coherentmarketinsights.com/insight/request-pdf/3921

The high rate of infertility is likely to drive growth in the global human reproductive technologies market over the estimated period. For example, according to the National Survey of Family Growth Data published in September 2018, in the US, 15.5% of women who want to become pregnant are infertile and 6.7% of married women between the ages of 15 and 44 are infertile.

Research and development in the diagnosis of infertility is likely to provide beneficial growth opportunities for players in the global human reproductive technologies market. For example, DiaSorin S.p.A launched the LIAISON test in May 2018 to measure sex hormone-binding globulin in human serum and plasma for the diagnosis of infertility, and erectile dysfunction in men, and polycystic syndrome in women.

Side effects related to the use of contraceptives and devices are likely to obstruct market growth. Long-term side effects related to oral contraceptive pills, like as breast cancer, blood clots, and an increased risk of heart disease, are strongly discouraged.

Market Trends

Initiatives to raise awareness about human reproductive technologies are likely to drive market growth. For example, Cryos USA, the US-based sperm and egg bank, held a scientific seminar on auxiliary reproductive technology (ART) in February 2020.

The use of machine learning and artificial intelligence (AI) to diagnose infertility is on the rise. Researchers at Peking University, China, for example, proposed in May 2020 a special convoluted neural network architecture for accurate classification of human sperm heads based on sperm images.

Global Human Reproductive Technologies Market: Key Developments

January 2020: Bayer Healthcare AG signs a licensing agreement with Daré Bioscience, Inc., a provider of products for women's health, under which Bayer can commercialize Daré's investigative contraceptive product, Ovaprene, in the US once approved by the USFDA.

May 2020: Ferring Pharmaceuticals announces that Menotropin is a comparable to Menotropin for the development of multiple follicles and injections indicated for pregnancy in menopausal-assisted reproductive technology (ART) programs. Endpoint, menopausal-treated patients begin 35.5% OPR per cycle after a new transfer.

Get Access of Our Latest Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/3921

Competitive Landscape
Key players performing in the global human reproductive technologies are Merck Serono, Daré Bioscience Inc., Johnson & Johnson, Ferring Pharmaceuticals, Cook Medical Inc., Pantarhei Bioscience B.V., Mayer Laboratories Inc., BioSante Pharmaceuticals Inc., Agile Therapeutics Inc., Pfizer Inc., Allergan, Bayer HealthCare AG, Merck & Co, Cryos USA, Mankind Pharma, HRA Pharma, SA, Aurobindo Pharma Limited, Sandoz International GmbH, Gavis Pharmaceuticals (Lupin Limited), Uniprix, Perrigo Company plc, Sun Pharmaceutical Industries Ltd., Actavis Generics (Teva Pharmaceutical Industries Ltd.), Evofem Biosciences Inc., and Abbott Laboratories.

Key Opportunities:

The report examines the key opportunities in the Human Reproductive Technologies Market and identifies the factors that are driving and will continue to drive the industry's growth. It takes into account past growth patterns, growth drivers, as well as current and future trends.

The Study Objectives are:

✔ A comprehensive insight into key players operating in the Human Reproductive Technologies Market and their corresponding data.

✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.

✔ Regional analysis, which includes insight into the dominant market and corresponding market share.

✔ It also includes various socio-economic factors affecting the evolution of the market in the region.

✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.

Regional Analysis: The Human Reproductive Technologies Market report is highly structured into a region-wise study. The regional analysis comprehensively done by the researchers highlights key regions and their dominating countries accounting for substantial revenue share in the market.

Following are the various regions covered by the Human Reproductive Technologies Market research report:

North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Russia, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, and Rest of APAC), South America (Brazil, Argentina, Columbia and Rest of Latin America), Middle East & Africa (Saudi Arabia, South Africa, Turkey, Nigeria, UAE and Rest of MEA)

Key Questions Answered:

What is the market size and CAGR of the Human Reproductive Technologies Market during the forecast period?

How is the growing demand impacting the growth of Human Reproductive Technologies Market shares?

What is the growing demand of the Human Reproductive Technologies Market during the forecast period?

Who are the leading vendors in the market and what are their market shares?

What is the impact of the COVID-19 pandemic on the APAC Human Reproductive Technologies Market?

Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/3921

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About us:

Coherent Market Insights is a global market intelligence and consulting firm that offers syndicated and customised research reports as well as consulting services. We're known for our actionable insights and reliable reports in a wide range of industries, including aerospace and defence, agriculture, food and beverage, automotive, chemicals and materials, and virtually every other domain and sub-domain imaginable. Our clients benefit from our highly reliable and accurate reports. We're also committed to continuing to provide measurable, long-term results for our clients after COVID-19 by playing a leading role in providing insights into various sectors.

This release was published on openPR.